Japan Immuno-Oncology Clinical Trials Market Size, Share, and COVID-19 Impact Analysis, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Design (Interventional Trials, Observational Trials, and Expanded Access Trials), By Indication (Solid Tumors and Hematological Cancer), and Japan Immuno-Oncology Clinical Trials Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jul 2025
REPORT ID SI13547
PAGES 216
REPORT FORMAT PathSoft

Request Free Sample

Your personal details will remain secure and confidential - Privacy Policy

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies